| Mohammed Najeeb Al Hallak, MD | |
|
4100 John R St, Detroit, MI 48201-2013 | |
| (800) 527-6266 | |
| Not Available |
| Full Name | Mohammed Najeeb Al Hallak |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 19 Years |
| Location | 4100 John R St, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205088556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301111399 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Karmanos Cancer Center | Detroit, MI | Hospital |
| Harper University Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physician Group | 8628087681 | 345 |
News Archive
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
At issue is how to pay for an extension of the current interest rate. Democrats propose increasing the Social Security and Medicare payroll taxes on high-earning stockholders of some privately owned corporations. Republicans would like to take funds from the health law's prevention fund.
President Barack Obama is expected to offer the outlines of an administrative fix to the problem some consumers are facing - health coverage cancellation notices. Obama is scheduled to make remarks from the White House at 11:35 a.m.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
› Verified 8 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
At issue is how to pay for an extension of the current interest rate. Democrats propose increasing the Social Security and Medicare payroll taxes on high-earning stockholders of some privately owned corporations. Republicans would like to take funds from the health law's prevention fund.
President Barack Obama is expected to offer the outlines of an administrative fix to the problem some consumers are facing - health coverage cancellation notices. Obama is scheduled to make remarks from the White House at 11:35 a.m.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
› Verified 8 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
At issue is how to pay for an extension of the current interest rate. Democrats propose increasing the Social Security and Medicare payroll taxes on high-earning stockholders of some privately owned corporations. Republicans would like to take funds from the health law's prevention fund.
President Barack Obama is expected to offer the outlines of an administrative fix to the problem some consumers are facing - health coverage cancellation notices. Obama is scheduled to make remarks from the White House at 11:35 a.m.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammed Najeeb Al Hallak, MD 4100 John R St, Detroit, MI 48201-2013 Ph: (800) 527-6266 | Mohammed Najeeb Al Hallak, MD 4100 John R St, Detroit, MI 48201-2013 Ph: (800) 527-6266 |
News Archive
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
At issue is how to pay for an extension of the current interest rate. Democrats propose increasing the Social Security and Medicare payroll taxes on high-earning stockholders of some privately owned corporations. Republicans would like to take funds from the health law's prevention fund.
President Barack Obama is expected to offer the outlines of an administrative fix to the problem some consumers are facing - health coverage cancellation notices. Obama is scheduled to make remarks from the White House at 11:35 a.m.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.
› Verified 8 days ago
Dr. Saba Alan Francis, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |